Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

Shashi Bhushan B L; Sunil Wanve; Parshottam Koradia; Vinay Bhomia; Pravin Soni; Sisir Chakraborty; Akash Khobragade; Shashank Joshi; Sanjeev Kumar Mendiratta; Kevin Kumar Kansagra; Anurag Parihar; Sunil Sharma; Jatin Patel

International Journal of Infectious Diseases (2021) - Comments
doi: 10.1016/j.ijid.2021.08.044 issn: 1201-9712 pubmed: 34428542 issn: 1878-3511

Shashi Bhushan B L, Sunil Wanve, Parshottam Koradia, Vinay Bhomia, Pravin Soni, Sisir Chakraborty, Akash Khobragade, Shashank Joshi, Sanjeev Kumar Mendiratta, Kevin Kumar Kansagra, Anurag Parihar, Sunil Sharma, Jatin Patel